Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

Antiandrogen therapy may help treat hidradenitis suppurativa.

Hair India 2012 was a successful international event focused on combating fake trichology practices and discussing various hair health topics.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Antibody treatments show promise for hair loss but need more research.

New acne treatments show promise as alternatives to traditional therapies.

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Hair loss in women may have causes other than hormones.

MC4R gene variants not linked to female hair loss.

No link found between specific genes and female pattern hair loss.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Too much androgen can cause hair loss; finasteride may help.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Androgens slow hair growth by altering Wnt signaling in balding cells.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Treatment during development affects hormone balance and sexual behavior in male rats.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.